Table 2
APOE genotype distributions for control and cataract groups
| APOE genotype | Observed frequency | |||||
|---|---|---|---|---|---|---|
| Cataracts | ||||||
| Controls (n = 187) | Nuclear (n = 77) | Cortical (n = 155) | Posterior subcapsular (n = 119) | Mixed (n = 151) | All Cases (n = 502) | |
| p>0.05 for all genotypes when comparing controls and cataracts (all cases) or cataract subgroups. 95% confidence intervals of all odds ratios included 1.0 (no difference). | ||||||
| NO, not observed. | ||||||
| ε2/ε2 | 0.011 | 0.013 | 0.013 | 0.017 | 0.020 | 0.016 |
| ε2/ε3 | 0.182 | 0.156 | 0.181 | 0.101 | 0.179 | 0.157 |
| ε2/ε4 | 0.021 | 0.039 | 0.019 | 0.008 | 0.033 | 0.024 |
| ε3/ε3 | 0.588 | 0.636 | 0.587 | 0.697 | 0.596 | 0.624 |
| ε3/ε4 | 0.187 | 0.156 | 0.194 | 0.168 | 0.166 | 0.173 |
| ε4/ε4 | 0.011 | NO | 0.006 | 0.008 | 0.007 | 0.006 |
